Phase II study of induction platinum doublet in combination with nivolumab followed by surgery or concurrent chemotherapy-nivolumab-radiation in unresectable stage IIIA-C non-small cell lung cancer (NSCLC)

被引:0
|
作者
Zinner, Ralph
Meyerson, Shari L.
McGarry, Ronald C.
Mullett, Timothy W.
Villano, John L.
Hao, Zhonglin
Yang, Eddy Shih-Hsin
Miller, Jordan D.
Shah-Jadeja, Mansi M.
Morgan, Clinton T.
Maskey, Ashish P.
Bernard, Mark E.
Yan, Weisi
Yan, Donglin
McLouth, Laurie
Ming-Yuan, Boris
Cornette, Abagail L.
Phelps, Mitch A.
Kneuertz, Peter J.
Carbone, David Paul
机构
[1] Univ Kentucky, Comprehens Canc Ctr, Lexington, KY USA
[2] Univ Kentucky, Coll Dept Behav Hlth, Lexington, KY USA
[3] Univ Kentucky, Dept Human Hlth Sci, Lexington, KY USA
[4] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[5] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[6] Pelotonia Inst Immunooncol, Columbus, OH USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
TPS8122
引用
收藏
页数:1
相关论文
共 50 条
  • [1] A phase II study of concurrent pemetrexed/cisplatin/radiation (RT) for unresectable stage IIIA/b non-small cell lung cancer (NSCLC)
    Brade, A. M.
    Bezjak, A.
    MacRae, R. M.
    Laurie, S. A.
    Wang, L.
    Capobianco, S.
    Shepherd, F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] A PHASE II STUDY OF CONCURRENT PEMETREXED (P)/CISPLATIN (C)/RADIATION (RT) FOR UNRESECTABLE STAGE IIIA/B NON-SMALL CELL LUNG CANCER (NSCLC)
    Brade, A.
    Bezjak, A.
    MacRae, R.
    Laurie, S.
    Cho, J.
    Hope, A.
    Sun, A.
    Wang, L.
    Capobianco, S.
    Iscoe, N.
    Shepherd, F.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S19 - S19
  • [3] A PHASE II STUDY EVALUATING CONCURRENT PEMETREXED/CISPLATIN/RADIATION (RT) FOR UNRESECTABLE STAGE IIIA/B NON-SMALL CELL LUNG CANCER (NSCLC)
    Brade, Anthony M.
    Bezjak, Andrea
    Macrae, Robert
    Laurie, Scott A.
    Burkes, Ronald
    Chu, Quincy
    Wang, Lisa
    Goffin, John R.
    Grishma, Sheth
    Capobianco, Stephanie
    Iscoe, Neill
    Shepherd, Frances A.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1543 - S1544
  • [4] Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer
    Weisman, Michael
    Durm, Greg
    Shields, Misty Dawn
    Hanna, Nasser H.
    Althouse, Sandra
    Lautenschlaeger, Tim
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2025, 121 (03): : 720 - 727
  • [5] Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer
    Weisman, Michael
    Durm, Greg
    Shields, Misty Dawn
    Hanna, Nasser H.
    Althouse, Sandra
    Lautenschlaeger, Tim
    International Journal of Radiation Oncology Biology Physics, 2024,
  • [6] Evaluation of Pneumonitis in a Phase ll Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab Alone following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non small Cell Lung Cancer (NSCLC)
    Weisman, M.
    Shields, M.
    Althouse, S.
    Durm, G.
    Lautenschlaeger, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S168 - S169
  • [7] Induction chemotherapy followed by concurrent chemoradiotherapy in stage III unresectable non-small cell lung cancer
    Tan, EH
    Wee, J
    Ang, PT
    Fong, KW
    Leong, SS
    Khoo, KS
    Tan, T
    Lee, KS
    Eng, P
    Hsu, A
    Tan, YK
    Chua, EJ
    Ong, YY
    ACTA ONCOLOGICA, 1999, 38 (08) : 1005 - 1009
  • [8] Veliparib and nivolumab in combination with platinum doublet chemotherapy in patients with metastatic or advanced non-small cell lung cancer: A phase 1 dose escalation study
    Clarke, Jeffrey M.
    Patel, Jyoti D.
    Robert, Francisco
    Kio, Ebenezer A.
    Thara, Eddie
    Camidge, D. Ross
    Dunbar, Martin
    Nuthalapati, Silpa
    Dinh, Minh H.
    Bach, Bruce A.
    LUNG CANCER, 2021, 161 : 180 - 188
  • [9] Concurrent Pemetrexed/Cisplatin/Radiation for unresectable stage IIIA/B non-small cell lung cancer: A phase I/II study
    Brade, A. M.
    Bezjak, A.
    MacRae, R.
    Laurie, S.
    Pond, G. R.
    Afinec, A.
    Iscoe, N.
    Shepherd, F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S490 - S490
  • [10] Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non-Small Cell Lung Cancer
    Brade, Anthony
    MacRae, Robert
    Laurie, Scott A.
    Bezjak, Andrea
    Burkes, Ronald
    Chu, Quincy
    Goffin, John R.
    Cho, John
    Hope, Andrew
    Sun, Alex
    Leighl, Natasha
    Capobianco, Stephanie
    Feld, Ronald
    Mahalingam, Essai
    Hossain, Anwar
    Iscoe, Neill
    Shepherd, Frances A.
    CLINICAL LUNG CANCER, 2016, 17 (02) : 133 - 141